cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.20308884
title: Supplementary Material for: Roles for SGLT2 Inhibitors in Cardiorenal Disease

description: Cardiovascular disease (CVD) and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2DM). In cardiovascular outcome studies of patients with T2DM, sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy was associated with risk reductions in cardiorenal endpoints. This article aims to provide a comprehensive overview of the efficacy of SGLT2i therapy in patients at risk of cardiorenal disease. A literature review of large outcome studies of patients who had CKD or heart failure with reduced ejection fraction (HFrEF, defined as having a left ventricle ejection fraction [LVEF] &lt;40%) or heart failure with preserved ejection fraction (LVEF ≥50%) was undertaken to evaluate the associations between SGLT2i use and cardiorenal events. In the cardiorenal outcome studies, patients with CKD who received canagliflozin or dapagliflozin had a lowered risk of a sustained decline in kidney function, end-stage kidney disease, or death from renal or cardiovascular (CV) causes than patients who received placebo. In outcome studies that enrolled patients with HFrEF, dapagliflozin, empagliflozin, and sotagliflozin lowered the risk of the composite endpoint of CV death and hospitalization for heart failure (HHF) versus placebo, an effect driven largely by a reduced risk of HHF. SGLT2i therapy was associated with risk reductions in the CV death/HHF composite and stand-alone HHF endpoints in patients with CKD. Conversely, patients with HFrEF attained renal benefit from SGLT2i use. The efficacy of SGLT2i was observed across a diverse range of patient subgroups. SGLT2i therapy has been found to substantially mitigate cardiorenal morbidity in patients with CKD or HFrEF, regardless of the presence of T2DM, and severity of CKD or HF.
DOI: 10.6084/m9.figshare.20308884.v2
title: Supplementary Material for: Roles for SGLT2 Inhibitors in Cardiorenal Disease

description: Cardiovascular disease (CVD) and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2DM). In cardiovascular outcome studies of patients with T2DM, sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy was associated with risk reductions in cardiorenal endpoints. This article aims to provide a comprehensive overview of the efficacy of SGLT2i therapy in patients at risk of cardiorenal disease. A literature review of large outcome studies of patients who had CKD or heart failure with reduced ejection fraction (HFrEF, defined as having a left ventricle ejection fraction [LVEF] &lt;40%) or heart failure with preserved ejection fraction (LVEF ≥50%) was undertaken to evaluate the associations between SGLT2i use and cardiorenal events. In the cardiorenal outcome studies, patients with CKD who received canagliflozin or dapagliflozin had a lowered risk of a sustained decline in kidney function, end-stage kidney disease, or death from renal or cardiovascular (CV) causes than patients who received placebo. In outcome studies that enrolled patients with HFrEF, dapagliflozin, empagliflozin, and sotagliflozin lowered the risk of the composite endpoint of CV death and hospitalization for heart failure (HHF) versus placebo, an effect driven largely by a reduced risk of HHF. SGLT2i therapy was associated with risk reductions in the CV death/HHF composite and stand-alone HHF endpoints in patients with CKD. Conversely, patients with HFrEF attained renal benefit from SGLT2i use. The efficacy of SGLT2i was observed across a diverse range of patient subgroups. SGLT2i therapy has been found to substantially mitigate cardiorenal morbidity in patients with CKD or HFrEF, regardless of the presence of T2DM, and severity of CKD or HF.
DOI: 10.6084/m9.figshare.20308884.v1
title: Supplementary Material for: Roles for SGLT2 Inhibitors in Cardiorenal Disease

description: Cardiovascular disease (CVD) and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2DM). In cardiovascular outcome studies of patients with T2DM, sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy was associated with risk reductions in cardiorenal endpoints. This article aims to provide a comprehensive overview of the efficacy of SGLT2i therapy in patients at risk of cardiorenal disease. A literature review of large outcome studies of patients who had CKD or heart failure with reduced ejection fraction (HFrEF, defined as having a left ventricle ejection fraction [LVEF] &lt;40%) or heart failure with preserved ejection fraction (LVEF ≥50%) was undertaken to evaluate the associations between SGLT2i use and cardiorenal events. In the cardiorenal outcome studies, patients with CKD who received canagliflozin or dapagliflozin had a lowered risk of a sustained decline in kidney function, end-stage kidney disease, or death from renal or cardiovascular (CV) causes than patients who received placebo. In outcome studies that enrolled patients with HFrEF, dapagliflozin, empagliflozin, and sotagliflozin lowered the risk of the composite endpoint of CV death and hospitalization for heart failure (HHF) versus placebo, an effect driven largely by a reduced risk of HHF. SGLT2i therapy was associated with risk reductions in the CV death/HHF composite and stand-alone HHF endpoints in patients with CKD. Conversely, patients with HFrEF attained renal benefit from SGLT2i use. The efficacy of SGLT2i was observed across a diverse range of patient subgroups. SGLT2i therapy has been found to substantially mitigate cardiorenal morbidity in patients with CKD or HFrEF, regardless of the presence of T2DM, and severity of CKD or HF.
DOI: 10.5281/zenodo.7031239
title: Mappability tracks for human assemblies (hg19 and GRCh38)

description: They were created by using the GEM mapper aligner (Derrien et al., 2012) allowing up to two mismatches and considering sliding windows of 100-mer. They are exploited by the EXCAVATOR2 tool for reducing technical biases of Read Count measure in WES/TS experiments.
DOI: 10.5281/zenodo.7031238
title: Mappability tracks for human assemblies (hg19 and GRCh38)

description: They were created by using the GEM mapper aligner (Derrien et al., 2012) allowing up to two mismatches and considering sliding windows of 100-mer. They are exploited by the EXCAVATOR2 tool for reducing technical biases of Read Count measure in WES/TS experiments.
DOI: 10.5517/ccdc.csd.cc29xz07
title: CCDC 2142999: Experimental Crystal Structure Determination

description: Related Article: Yuanshan Huang, Xin Zheng, Zizhu Yao, Wei Lv, Shengchang Xiang, Qidan Ling, Zhenghuan Lin|2022|Chem.Eng.Journal|444|136629|doi:10.1016/j.cej.2022.136629
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b0b2s
title: CCDC 2145264: Experimental Crystal Structure Determination

description: Related Article: Michael Tapera, Hüseyin Kekeçmuhammed, Kader Sahin, Vagolu Siva Krishna, Christian Lherbet, Håvard Homberset, Mélina Chebaiki, Tone Tønjum, Lionel Mourey, Yunus Zorlu, Serdar Durdagi, Emin Sarıpınar|2022|J.Mol.Struct.|1270|133899|doi:10.1016/j.molstruc.2022.133899
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b88pl
title: CCDC 2152909: Experimental Crystal Structure Determination

description: Related Article: Qinghe Gao, Zhenhua Sun, Manman Wu, Yimei Guo, Xinya Han, Jufen Yan, Minh Ngoc Ha, Quynh Mai Le, Yongtao Xu|2022|Org.Chem.Front.|9|3050|doi:10.1039/D2QO00381C
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bdn1g
title: CCDC 2157105: Experimental Crystal Structure Determination

description: Related Article: Zhichao Wang, Shoko Yamazaki, Yuji Mikata, Miho Oba, Hiroshi Takashima, Tsumoru Morimoto, Akiya Ogawa|2022|J.Org.Chem.|87|11148|doi:10.1021/acs.joc.2c01417
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5281/zenodo.7031975
title: Heavy metal

description: The dataset in the figures of <strong>Measurement Report: </strong><strong>Rapid changes of chemical characteristics and health risks for high time-resolved trace elements in PM<sub>2.5</sub> in a typical industrial city response to stringent clean air actions</strong>
DOI: 10.5281/zenodo.7031974
title: Heavy metal

description: The dataset in the figures of <strong>Measurement Report: </strong><strong>Rapid changes of chemical characteristics and health risks for high time-resolved trace elements in PM<sub>2.5</sub> in a typical industrial city response to stringent clean air actions</strong>
DOI: 10.6084/m9.figshare.20704378
title: parabuteo_unicinctus_zanfona_1.fasta.gz

description: .....
DOI: 10.6084/m9.figshare.20704378.v1
title: parabuteo_unicinctus_zanfona_1.fasta.gz

description: .....
DOI: 10.34740/kaggle/dsv/4135113
title: YouTube Trending Video Dataset (updated daily)
DOI: 10.6084/m9.figshare.20704423
title: polyboroides_typus_zanfona_1.fasta.gz

description: .....
DOI: 10.6084/m9.figshare.20704423.v1
title: polyboroides_typus_zanfona_1.fasta.gz

description: .....
DOI: 10.5281/zenodo.7030451
title: Supplementary materials of the paper entitled: "Metamorphic Testing Meets Regression Testing: A Case Study of Scientific Software Maintenance"

description: Supplementary materials of the paper entitled: “Metamorphic Testing Meets Regression Testing: A Case Study of Scientific Software Maintenance” file01 - source code for detecting and comparing output relations of a given metamorphic relation<br> file02 - interview transcripts and qualitative coding results<br> file03 - system script for compiling SWMM, creating sSWMM simulation outputs, and logging execution time<br> file04 - source code for SWMM 5.1.014<br> file05 - source code for SWMM 5.1.015<br> file06 - a suite of 40 regression tests (40 .inp files)<br> file07 - result table for 760 cases (19 MRs × 40 .inp files)<br> file08 - 491 automatically generated follow-up .inp files via reuse<br> file09 - result table for mutation analysis<br> file10 - output files for mutation analysis with metamorphic testing:<br> a. Original source output<br> b. Original follow-up output<br> c. Mutant source output<br> d. Mutant follow-up output
DOI: 10.5281/zenodo.7030450
title: Supplementary materials of the paper entitled: "Metamorphic Testing Meets Regression Testing: A Case Study of Scientific Software Maintenance"

description: Supplementary materials of the paper entitled: “Metamorphic Testing Meets Regression Testing: A Case Study of Scientific Software Maintenance” file01 - source code for detecting and comparing output relations of a given metamorphic relation<br> file02 - interview transcripts and qualitative coding results<br> file03 - system script for compiling SWMM, creating sSWMM simulation outputs, and logging execution time<br> file04 - source code for SWMM 5.1.014<br> file05 - source code for SWMM 5.1.015<br> file06 - a suite of 40 regression tests (40 .inp files)<br> file07 - result table for 760 cases (19 MRs × 40 .inp files)<br> file08 - 491 automatically generated follow-up .inp files via reuse<br> file09 - result table for mutation analysis<br> file10 - output files for mutation analysis with metamorphic testing:<br> a. Original source output<br> b. Original follow-up output<br> c. Mutant source output<br> d. Mutant follow-up output
DOI: 10.5517/ccdc.csd.cc1khf3l
title: CSD 1444789: Experimental Crystal Structure Determination

description: Related Article: Ailijiang Abudurusuli, Kui Wu, Abudukadi Tudi, Zhihua Yang, Shilie Pan|2019|Chem.Commun.|55|5143|doi:10.1039/C9CC00560A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc1khf4m
title: CSD 1444790: Experimental Crystal Structure Determination

description: Related Article: Ailijiang Abudurusuli, Kui Wu, Abudukadi Tudi, Zhihua Yang, Shilie Pan|2019|Chem.Commun.|55|5143|doi:10.1039/C9CC00560A
description: An entry from the Inorganic Crystal Structure Database, the world’s repository for inorganic crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the joint CCDC and FIZ Karlsruhe Access Structures service and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2b4xcs
title: CCDC 2149675: Experimental Crystal Structure Determination

description: Related Article: Xiaoyang Xu, Mengjia Jin, Ruijun Jiang, Lei Zhang, Xiaoming Wu, Xuguang Liu|2022|J.Org.Chem.|87|6630|doi:10.1021/acs.joc.2c00278
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bhvnc
title: CCDC 2160193: Experimental Crystal Structure Determination

description: Related Article: Qingqiang Tian, Boqun Pei, Chuxia Wang, Chiying Zhang, Yahui Li|2022|J.Org.Chem.|87|10908|doi:10.1021/acs.joc.2c01197
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.20711686
title: RawData_LaPerouse2019.zip

description: <strong>Abstract: </strong> Mesophotic marine ecosystems are characterized by lower light penetration supporting specialized fish fauna. Due to their depths (-30 to -150 m), accessibility is challenging, and the structure of mesophotic fish assemblages is generally less known than either shallow reefs or deep zones with soft bottoms which are generally trawled. Environmental DNA metabarcoding from seawater filtered <em>in situ</em> could improve our ability to monitor the diversity of mesophotic ecosystems. Here, we developed and tested a submersible standalone pumping device allowing targeted marine water filtering to explore the biodiversity of two mesophotic ecosystems, one temperate along the Provence coast in the North-Western Mediterranean Sea and one tropical at the seamount La Pérouse in the Western Indian Ocean. We filtered water samples from depths ranging between 0 and 200 m in the Mediterranean Sea and between 60 and 140 m in the Indian Ocean and applied a metabarcoding protocol using the teleo primer pair targeting the 12S mitochondrial rDNA (Actinopterygii and Chondrichthyes). For both study regions, our eDNA survey was able to recover highly diverse fish assemblages and the compositional analysis of eDNA samples showed both a marked signal of fish compositional turnover and overlapping taxa between depth zones. Further, we observed that a substantial number of species were found in samples collected in depths beyond their reported depth range suggesting an underestimation of species’ depth tolerances. eDNA metabarcoding should thus complement existing knowledge of species' geographic distributions across space and depth. Overall, our results demonstrate the potential of eDNA metabarcoding for future mesophotic surveys as it allows fast and broad biodiversity assessment. <br> <strong>Data set:</strong> These data sets include the raw data of La Pérouse of the Environmental DNA article "Environmental DNA highlights fish biodiversity in mesophotic ecosystems".
DOI: 10.5519/qd.exmmsi1x
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (3 records)
DOI: 10.34740/kaggle/dsv/4135249
title: 2021 World Population (updated daily)
DOI: 10.5517/ccdc.csd.cc27xqjf
title: CCDC 2083185: Experimental Crystal Structure Determination

description: Related Article: William J. M. Blackaby, Katie L. M. Harriman, Samuel M. Greer, Andrea Folli, Stephen Hill, Vera Krewald, Mary F. Mahon, Damien M. Murphy, Muralee Murugesu, Emma Richards, Elizaveta Suturina, Michael K. Whittlesey|2022|Inorg.Chem.|61|1308|doi:10.1021/acs.inorgchem.1c02413
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc27xqkg
title: CCDC 2083186: Experimental Crystal Structure Determination

description: Related Article: William J. M. Blackaby, Katie L. M. Harriman, Samuel M. Greer, Andrea Folli, Stephen Hill, Vera Krewald, Mary F. Mahon, Damien M. Murphy, Muralee Murugesu, Emma Richards, Elizaveta Suturina, Michael K. Whittlesey|2022|Inorg.Chem.|61|1308|doi:10.1021/acs.inorgchem.1c02413
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc27xqlh
title: CCDC 2083187: Experimental Crystal Structure Determination

description: Related Article: William J. M. Blackaby, Katie L. M. Harriman, Samuel M. Greer, Andrea Folli, Stephen Hill, Vera Krewald, Mary F. Mahon, Damien M. Murphy, Muralee Murugesu, Emma Richards, Elizaveta Suturina, Michael K. Whittlesey|2022|Inorg.Chem.|61|1308|doi:10.1021/acs.inorgchem.1c02413
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc27xqmj
title: CCDC 2083188: Experimental Crystal Structure Determination

description: Related Article: William J. M. Blackaby, Katie L. M. Harriman, Samuel M. Greer, Andrea Folli, Stephen Hill, Vera Krewald, Mary F. Mahon, Damien M. Murphy, Muralee Murugesu, Emma Richards, Elizaveta Suturina, Michael K. Whittlesey|2022|Inorg.Chem.|61|1308|doi:10.1021/acs.inorgchem.1c02413
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc27xqnk
title: CCDC 2083189: Experimental Crystal Structure Determination

description: Related Article: William J. M. Blackaby, Katie L. M. Harriman, Samuel M. Greer, Andrea Folli, Stephen Hill, Vera Krewald, Mary F. Mahon, Damien M. Murphy, Muralee Murugesu, Emma Richards, Elizaveta Suturina, Michael K. Whittlesey|2022|Inorg.Chem.|61|1308|doi:10.1021/acs.inorgchem.1c02413
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc29g4hf
title: CCDC 2128754: Experimental Crystal Structure Determination

description: Related Article: Hao Peng, Jingli Lou, Ganggang Li, Changjiang Zhou, Zhiming Wang, He Liu|2022|J.Mater.Chem.C|10|5813|doi:10.1039/D2TC00212D
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bfbmr
title: CCDC 2157774: Experimental Crystal Structure Determination

description: Related Article: Mohammad Reza Anizadeh, Mohammad Ali Zolfigol, Morteza Torabi, Meysam Yarie, Behrouz Notash|2022|J.Mol.Liq.|364|120016|doi:10.1016/j.molliq.2022.120016
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bn87j
title: CCDC 2164427: Experimental Crystal Structure Determination

description: Related Article: Worakrit Saiyasombat, Utt Eiamprasert, Teera Chantarojsiri, Kittipong Chainok, Supavadee Kiatisevi|2022|Dyes Pigm.|206|110643|doi:10.1016/j.dyepig.2022.110643
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.25625/75c01m/cwtjjy
title: ENERGIES_XYZ_STRUCTURES.tab

description: Energies of computed xyz structures
DOI: 10.25625/75c01m/fswf3b
title: rkr_20210120_ArOMeZnPh2_1400_17.xy

description: :unav
DOI: 10.25625/75c01m/05rk5z
title: rkr_20210119_Ph3Zn_300_34.xy

description: :unav
DOI: 10.25625/75c01m/d7yvt9
title: rkr_20201210_ArFZnPh2_1200_28.xy

description: :unav
DOI: 10.25625/75c01m/qccbsi
title: rkr_20210120_ArNMe2ZnPh2_2000_21.xy

description: :unav
DOI: 10.25625/75c01m/zcfftq
title: rkr_20201124_Ph3Zn_900_13.xy

description: :unav
DOI: 10.25625/75c01m/85edru
title: rkr_20210119_ArNMe2ZnPh2_500_09.xy

description: :unav
DOI: 10.25625/75c01m/csn8dc
title: rkr_20210121_ArFZnPh2_500_31.xy

description: :unav
DOI: 10.25625/75c01m/inf7e4
title: rkr_20210121_ArFZnPh2_200_06.xy

description: :unav
DOI: 10.25625/75c01m/rjcvlt
title: rkr_20201210_ArOMeZnPh2_300_37.xy

description: :unav
DOI: 10.25625/75c01m/6oqkxb
title: rkr_20210120_ArOMeZnPh2_300_07.xy

description: :unav